Biomedical subjects

Alberto Martinez-Arizala

Publications and source records attributed to Alberto Martinez-Arizala.

6 recordsLinked to original sources

PubMed2006

Internal consistency, stability, and validity of the spinal cord injury version of the multidimensional pain inventory.

OBJECTIVE: To evaluate the internal consistency, stability, and construct validity of a spinal cord injury (SCI) version of the Multidimensional Pain Inventory (MPI-SCI). DESIGN: Interview. SETTING: Veterans Affairs medical center and university-based institute. PARTICIPANTS: Community sample of persons with SCI and chronic pain (N=161). INTERVENTIONS: Not applicable. MAIN OUTCOME MEASURE: The MPI-SCI. RESULTS: The internal consistency of the MPI-SCI subscales ranged from fair (.60) for affective distress to substantial (.94) for pain interference with activities. The subscales of the MPI-SCI (ie, life interference [r=.81], affective distress [r=.71], solicitous responses [r=.86], distracting responses [r=.85], general activity [r=.69], pain interference with activities [r=.78], pain severity [r=.69], negative responses [r=.69]) showed adequate stability. In contrast, the stability of the support (r=.59) and the life control subscales (r=.31) was unacceptably low. All MPI-SCI subscales with the exception of the perceived responses by significant others subscales showed good convergent, discriminant, and concurrent validity. CONCLUSIONS: The MPI-SCI appears to be a reasonable measure for evaluating chronic pain impact after SCI. In clinical trials, however, supplementary instruments should be included to assess changes in affect, social support, and perceptions of life control.

Adult↗

PubMed2005

Evidence for an exaggerated postprandial lipemia in chronic paraplegia.

BACKGROUND/OBJECTIVE: Excessive delay in triglyceride (TG) metabolism after ingestion of dietary fat represents a significant cardiovascular disease (CVD) risk. The objective of this study was to compare the postprandial lipemic responses of individuals with paraplegia with those of healthy nondisabled individuals. METHODS: The ability of 3 recreationally active individuals with paraplegia having normal fasting TG (mean = 103 mg/dL) to metabolize TG after ingestion of a high-fat test meal was compared with a previously published cohort of 21 recreationally active individuals without paraplegia (TG mean = 86 mg/dL) who underwent identical testing. The subjects with paraplegia had venous blood taken under fasting conditions, and then ingested a milkshake containing premium ice cream blended with heavy whipping cream (approximately 92% of calories from fat). Additional blood samples were obtained at 2, 4, and 6 hours after ingestion. The area under the curve (AUC) for TG clearance for both subject groups was measured with an area planimeter. RESULTS: TG uptake for both groups was almost identical for the first 2 hours after ingestion. At 4 and 6 hours after ingestion, the TG levels were 50 and 35 mg/dL higher, respectively, in subjects with paraplegia than in nondisabled subjects. When corrected for small baseline differences in TG concentrations (16 mg/dL), the AUC was 46.5% greater for the group with paraplegia than in the nondisabled group. A near mirror association across time was observed between postprandial serum high-density lipoprotein cholesterol (HDL-C) and TG levels in subjects with paraplegia. CONCLUSION: This case series finds an exaggerated postprandial lipemia (PPL) in persons with paraplegia with normal fasting TGs. This finding is the first evidence, in a small population, of an unreported potential CVD risk in persons with paraplegia.

Adult↗

PubMed2002

Diabetic demyelinating polyneuropathy responsive to intravenous immunoglobulin therapy.

BACKGROUND: There is growing evidence that idiopathic chronic inflammatory demyelinating polyneuropathy (CIDP) and polyneuropathy in patients with diabetes mellitus (DM) that meets the electrophysiological criteria for CIDP (DM-CIDP) have many similarities. OBJECTIVE: To evaluate whether DM-CIDP responds to intravenous immunoglobulin (IVIG) therapy. PATIENTS AND METHODS: Twenty-six patients (mean [SD] age, 64 [8.9] years; age range, 40-80 years) with type 2 DM (n = 25), who met the electrophysiological criteria for CIDP, were given IVIG therapy (400 mg/kg body weight per day for 5 days) in a prospective open-label pilot study. All patients had quantitative evaluation using the Neuropathy Impairment Score at baseline and at the end of 4 weeks from the initiation of IVIG therapy. RESULTS: The mean Neuropathy Impairment Score improved significantly from baseline (mean [SD], 61.5 [26.0] points) to the end of the fourth week (33 [29.6] points; P<.00l). This clinically significant improvement occurred in 21 (80.8%) of the 26 patients. Conduction block occurred in 11 (42.3%) of the 26 patients; improvement in the Neuropathy Impairment Score was more frequent in patients who had a conduction block (11 of 11 patients) than in those who did not (10/15 [66.7%]; P =.03). Adverse reactions to IVIG included reversible renal dysfunction in 3 patients, flulike symptoms in 5, headache in 5, and chest pain and shortness of breath in 1. CONCLUSION: Although IVIG therapy seemed to improve DM-CIDP in this uncontrolled trial, a controlled trial is required for confirmation of our findings.

Adult↗

PubMedDate not supplied

Methods to measure sensory function in humans versus animals.

Sensation is perhaps one of the most complex senses. It allows us to experience our environment, and it provides ongoing feedback for the performance of accurate motor tasks. The present methods used for clinical testing of sensation in patients with spinal cord injury (SCI) rely on traditional techniques developed many years ago. This type of testing has been incorporated into the ASIA (American Spinal Injury Association) score, which has become the principal instrument for measuring the recovery of sensory function in humans. Unfortunately, the ASIA score lacks sophistication and is not quantitative. Similar shortcomings are found in the testing of sensation in experimental animal models of SCI. Although highly refined methods have been developed for the study of sensation and pain perception in animals, these methods have not been incorporated for measuring recovery of function in experimental SCI. A review of the available literature suggests that further refined and quantifiable tests need to be developed in this area.

Animals↗

PubMedDate not supplied

Chronicity of pain associated with spinal cord injury: A longitudinal analysis.

This study determined the stability of self-reported clinical pain characteristics and pain-induced interference with sleep and daily activities in people with spinal cord injury. The study followed up a previous survey that identified clinical pain patterns (i.e., neuropathic pain below the level of injury; upper-limb pain in tetraplegia; and severe, persistent pain). A confirmatory factor analysis (CFA) of the present study's data confirmed the previously observed pain patterns. The CFA also confirmed positive correlations between the surveys on individual pain characteristics (i.e., number of pain locations [r = 0.63, p < 0.001], number of descriptors [r = 0.61, p < 0.001], pain intensity [r = 0.68, p < 0.001], and temporal aspects [r = 0.47, p < 0.001]). Despite an overall stable clinical picture of pain, "aching" pain (p < 0.001) and sleep interference caused by pain (p < 0.001) significantly increased over time.

Adult↗

PubMedDate not supplied

Proton magnetic resonance spectroscopy of the thalamus in patients with chronic neuropathic pain after spinal cord injury.

BACKGROUND AND PURPOSE: Spinal cord injury (SCI) results in a number of consequences; one of the most difficult to manage is chronic neuropathic pain. Thus, defining the potential neural and biochemical changes associated with chronic pain after SCI is important because this may lead to development of new treatment strategies. Prior studies have looked at the thalamus, because it is a major sensory relay station. The purpose of our study was to define alterations in metabolites due to injury-induced functional changes in thalamic nuclei by using single-voxel stimulated echo acquisition mode MR spectroscopy. METHODS: Twenty-six men were recruited: 16 patients with SCI and paraplegia (seven with pain, nine without pain) and 10 healthy control subjects. Pain was evaluated in an interview, which included the collection of information concerning the location, quality, and intensity of pain, carefully identifing the dysesthetic neuropathic pain often seen in SCI. Localized single-voxel (8-cm(3) volume) proton spectra were acquired from the left and right thalami. RESULTS: The concentration of N-acetyl (NA) was negatively correlated with pain intensity (r = -0.678), and the t test showed that NA was significantly different between patients with pain and patients without pain (P =.006). Myo-inositol was positively correlated with pain intensity (r = 0.520); difference between patients with pain and those without pain was almost significant (P =.06). CONCLUSION: The observed differences in metabolites in SCI patients with and pain and in those without pain suggest anatomic, functional, and biochemical changes in the thalamic region.

Adult↗